Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Operating Results by Reportable Segment (Detail)

v3.10.0.1
Segment Information - Operating Results by Reportable Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Segment Reporting Information [Line Items]          
Net Revenue $ 63,693 $ 46,886 $ 182,952 $ 142,265  
National expenses 88,582 79,489 267,924 215,638  
Segment income (loss) from operations (24,889) (32,603) (84,972) (73,373)  
Segment assets 224,919   224,919   $ 245,950
Dermatology Products Sales [Member]          
Segment Reporting Information [Line Items]          
Net Revenue 5,168 2,170 17,366 8,309  
Direct cost of goods (1,406) (505) (4,546) (1,852)  
Sales and marketing costs (2,754) (2,786) (8,443) (7,663)  
Research and development 0 0 0 0  
General and administrative (505) (349) (1,270) (961)  
National expenses 0 0 0 0  
Segment income (loss) from operations 503 (1,470) 3,107 (2,167)  
Segment assets 10,765 7,362 10,765 7,362  
Pharmaceutical And Biotechnology Product Development [Member]          
Segment Reporting Information [Line Items]          
Net Revenue 5 350 525 1,393  
Direct cost of goods 0 0 0 0  
Sales and marketing costs 0 0 0 0  
Research and development (19,788) (16,190) (62,332) (38,077)  
General and administrative (8,925) (11,969) (29,075) (27,866)  
National expenses 0 0 0 0  
Segment income (loss) from operations (28,708) (27,809) (90,882) (64,550)  
Segment assets 157,781 160,038 157,781 160,038  
National [Member]          
Segment Reporting Information [Line Items]          
Net Revenue 58,520 44,366 165,061 132,563  
Direct cost of goods 0 0 0 0  
Sales and marketing costs 0 0 0 0  
Research and development 0 0 0 0  
General and administrative 0 0 0 0  
National expenses (55,204) (47,690) (162,258) (139,219)  
Segment income (loss) from operations 3,316 (3,324) 2,803 (6,656)  
Segment assets 56,373 77,691 56,373 77,691  
Consolidated [Member]          
Segment Reporting Information [Line Items]          
Net Revenue 63,693 46,886 182,952 142,265  
Direct cost of goods (1,406) (505) (4,546) (1,852)  
Sales and marketing costs (2,754) (2,786) (8,443) (7,663)  
Research and development (19,788) (16,190) (62,332) (38,077)  
General and administrative (9,430) (12,318) (30,345) (28,827)  
National expenses (55,204) (47,690) (162,258) (139,219)  
Segment income (loss) from operations (24,889) (32,603) (84,972) (73,373)  
Segment assets $ 224,919 $ 245,091 $ 224,919 $ 245,091